Clinical Trial Update: Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/Docetaxel [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant chemotherapy trial in breast cancer comparing epirubicin/docetaxel versus carboplatin/docetaxel; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)
• Epirubicin (epirubicin)

Snippet

Sponsor: Klinikum Weissenfels | Conditions: Primary Breast Cancer | Phase 2 | Status: COMPLETED